Grifols | GRFS - Market Capitalization


Grifols reported EUR2.41B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
Arca Biopharma USD 45M 339M Jun/2025
aTyr Pharma USD 60M 11M Feb/2026
Bio Path USD 3M 2M Jun/2025
Brainstorm Cell Therapeutics USD 29M 19M Jun/2025
Capricor Therapeutics USD 207M 227M Jun/2025
Cara Therapeutics USD 46M 23M Jun/2025
Esperion Therapeutics USD 340M 235M Dec/2023
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Grifols EUR 6.77B 773M Sep/2025
Immunic USD 68M 2M Dec/2023
Infinity Pharmaceuticals USD 19M 5M Jun/2023
Minerva Neurosciences USD 43M 5M Dec/2023
Nektar Therapeutics USD 113M 4M Sep/2023
TherapeuticsMD USD 24M 0 Mar/2024